These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7058823)

  • 21. Regulatory mechanisms of erythropoietin levels in dialysis patients.
    Tagawa H; Umezu M; Saito T; Yamakado M; Nagano M; Urabe A; Takaku F
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):297-303. PubMed ID: 2355666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin in children with chronic renal failure on dialytic and non-dialytic therapy.
    Aikhionbare HA; Winterborn MW; Gyde OH
    Int J Pediatr Nephrol; 1987; 8(1):9-14. PubMed ID: 3583560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of the hematocrit response to continuous ambulatory peritoneal dialysis.
    Steiner RW
    Arch Intern Med; 1984 Apr; 144(4):728-32. PubMed ID: 6712371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive parameters of erythropoietin hyporesponsiveness in patients on continuous ambulatory peritoneal dialysis.
    Kim JK; Park BS; Park MJ; Choi W; Ma SK; Nah MY; Yeum CH; Jung K; Lee SC; Kim SW; Kim NH; Kang YJ; Choi KC
    Korean J Intern Med; 2001 Jun; 16(2):110-7. PubMed ID: 11590897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematocrit and residual renal creatinine clearance in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nolph KD; Prowant BF; Moore HL; Reyad SE
    Perit Dial Int; 1990; 10(4):279-82. PubMed ID: 2096928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of recombinant erythropoietin on the early hematocrit rise after CAPD initiation.
    Golper TA
    Perit Dial Int; 1992; 12(1):37-9. PubMed ID: 1543778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group.
    Rocco MV; Flanigan MJ; Beaver S; Frederick P; Gentile DE; McClellan WM; Polder J; Prowant BF; Taylor L; Helgerson SD
    Am J Kidney Dis; 1997 Aug; 30(2):165-73. PubMed ID: 9261026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
    Madden MA; Zimmerman SW; Simpson DP
    Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
    Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
    Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M; Bartlett DK; Brier ME; Golper TA
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycythemia of end-stage renal failure: no inhibition of erythropoiesis by uremic serum and markedly increased serum erythropoietin level.
    Muto S; Asano Y; Hosoda S; Shionoya S; Miura Y; Urabe A; Takaku F
    Nephron; 1987; 46(1):34-6. PubMed ID: 3600910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
    Tokgöz B; Utaş C; Doğukan A; Oymak O; Keleştimur F
    Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.